| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 299 | 22.983 | 664.023 | 601.477 | 719.070 | 867.480 | 952.447 |
| Total Income - EUR | - | - | - | 299 | 22.983 | 676.759 | 604.556 | 719.451 | 867.894 | 953.028 |
| Total Expenses - EUR | - | - | - | 2.784 | 45.883 | 490.981 | 619.181 | 690.853 | 725.932 | 933.004 |
| Gross Profit/Loss - EUR | - | - | - | -2.485 | -22.899 | 185.779 | -14.625 | 28.598 | 141.962 | 20.024 |
| Net Profit/Loss - EUR | - | - | - | -2.488 | -23.129 | 178.371 | -19.766 | 21.547 | 130.260 | 16.992 |
| Employees | - | - | - | 0 | 2 | 9 | 24 | 22 | 25 | 0 |
Check the financial reports for the company - Noblesse Medical Clinique S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 510 | 230 | 42.605 | 65.637 | 72.930 | 50.061 | 47.887 |
| Current Assets | - | - | - | 1.468 | 1.888 | 260.777 | 116.403 | 58.849 | 146.721 | 99.247 |
| Inventories | - | - | - | 819 | 143 | 5.821 | 6.396 | 5.394 | 7.248 | 4.790 |
| Receivables | - | - | - | 3 | 171 | 105.604 | 40.224 | 28.644 | 94.868 | 40.448 |
| Cash | - | - | - | 647 | 1.574 | 149.352 | 69.782 | 24.811 | 44.605 | 54.009 |
| Shareholders Funds | - | - | - | -2.445 | -25.527 | 153.328 | 130.163 | 1.769 | 132.023 | 118.123 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 4.611 | 27.795 | 150.056 | 193.006 | 242.241 | 145.424 | 111.981 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Noblesse Medical Clinique S.r.l.